4//SEC Filing
Dudum Andrew 4
Accession 0001773751-25-000342
CIK 0001773751other
Filed
Oct 19, 8:00 PM ET
Accepted
Oct 20, 4:42 PM ET
Size
32.9 KB
Accession
0001773751-25-000342
Insider Transaction Report
Form 4
Dudum Andrew
DirectorChief Executive Officer10% Owner
Transactions
- Sale
Class A Common Stock
2025-10-16$62.65/sh−2,792$174,924→ 92,523 total - Sale
Class A Common Stock
2025-10-16$63.39/sh−2,335$148,009→ 109,190 total - Exercise/Conversion
Stock Option (right to buy)
2025-10-16−108,334→ 431,395 totalExercise: $2.43Exp: 2030-06-16→ Class A Common Stock (108,334 underlying) - Sale
Class A Common Stock
2025-10-16$63.46/sh−8,423$534,513→ 47,524 total(indirect: By Trust) - Sale
Class A Common Stock
2025-10-16$62.70/sh−16,667$1,044,969→ 92,523 total - Exercise/Conversion
Stock Option (right to buy)
2025-10-16−17,001→ 17,005 totalExercise: $2.43Exp: 2030-06-16→ Class A Common Stock (17,001 underlying) - Sale
Class A Common Stock
2025-10-16$62.70/sh−39,111$2,452,248→ 55,947 total(indirect: By Trust) - Sale
Class A Common Stock
2025-10-16$63.49/sh−10,469$664,627→ 150,857 total - Sale
Class A Common Stock
2025-10-16$62.69/sh−17,001$1,065,793→ 92,523 total - Exercise/Conversion
Class A Common Stock
2025-10-16$2.43/sh+108,334$263,252→ 200,857 total - Exercise/Conversion
Class A Common Stock
2025-10-16$2.43/sh+17,001$41,312→ 109,524 total - Sale
Class A Common Stock
2025-10-16$62.71/sh−39,531$2,478,803→ 161,326 total - Sale
Class A Common Stock
2025-10-16$62.70/sh−39,332$2,466,112→ 111,525 total
Holdings
- 1,286,627(indirect: By Trust)
Class A Common Stock
- 321,657(indirect: By Trust)
Class A Common Stock
- 1,584,506(indirect: By Trust)
Class A Common Stock
- 1,194,545(indirect: By Trust)
Class A Common Stock
- 1,016,871(indirect: By Trust)
Class A Common Stock
- 186,723(indirect: By Trust)
Class A Common Stock
- 508,030(indirect: By Trust)
Class A Common Stock
Footnotes (11)
- [F1]The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.
- [F10]Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.
- [F11]The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020.
- [F2]Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $62.50 - $62.87. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F3]Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $62.215 - $63.13. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F4]Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $63.31 - $63.59. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F5]Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $62.25 - $62.94. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F6]Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $62.22 - $63.18. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F7]Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $63.25 - $63.63. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F8]Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $62.22 - $63.20. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F9]Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $63.26 - $63.47. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Documents
Issuer
Hims & Hers Health, Inc.
CIK 0001773751
Entity typeother
Related Parties
1- filerCIK 0001837796
Filing Metadata
- Form type
- 4
- Filed
- Oct 19, 8:00 PM ET
- Accepted
- Oct 20, 4:42 PM ET
- Size
- 32.9 KB